Constitutive activation of mutant RAS in a human breast cancer model resulted in an increase in downstream pathway mediators such as mitogen-activated protein kinase (MAPK) and PI3K and in murine RAET1 ligand expression in mouse breast cancer cell lines [140]. Here, WNK2 is linked to breast carcinoma.